Technology explainer
How Do Scientists Grow Human Tissue From Stem Cells?
Scientists guide stem cells through timed developmental signals, organize multiple cell types in three dimensions, and use flow or mechanical cues to mature them. Research tissues can model disease and drugs, but vascularized, durable, safe implants require much more.
Short answer: scientists grow human tissue by starting with stem cells, exposing them to timed biochemical and mechanical cues that imitate development, arranging them in three dimensions, and maturing them in controlled culture. The result can model selected features of a tissue, but building a vascularized, innervated, mechanically durable, transplantable organ is a much harder task.
Choosing the starting cells
Pluripotent stem cells can produce almost any cell type in the body. They include embryonic stem cells and induced pluripotent stem cells (iPSCs), which are adult cells reprogrammed into a pluripotent state. Patient-derived iPSCs can preserve genetic features useful for disease modeling.
Researchers may instead use adult tissue stem cells, progenitor cells, or mature cells, depending on the goal. Adult stem cells usually have a narrower developmental range but may reproduce their native tissue more directly.
Cells need instructions, not just nutrients
During embryonic development, cells receive signals in a particular order and concentration. Laboratory protocols imitate selected parts of that sequence using growth factors, small molecules, hormones, extracellular matrix, oxygen, stiffness, electrical activity, and physical forces.
A signal can have opposite effects at different times. Researchers therefore control not only which molecule is present, but when it appears, how long it remains, and what the cells experienced earlier.
The core workflow
- Expand the starting population: grow enough healthy, genetically stable stem cells.
- Induce a developmental lineage: use signaling molecules to steer cells toward endoderm, mesoderm, or ectoderm and then a more specific fate.
- Separate or combine cell types: enrich the intended cells and add supporting populations such as fibroblasts, immune cells, or endothelial cells.
- Create three-dimensional organization: let cells self-organize or place them in a scaffold, gel, bioprinted pattern, or microfluidic device.
- Mature the construct: provide blood-like flow, stretching, electrical pacing, nutrients, and longer culture where appropriate.
- Validate identity and function: measure genes, proteins, structure, mechanics, metabolism, and response to relevant stimuli.
Four related systems
| System | What it is | Main strength | Main limitation |
|---|---|---|---|
| 2D cell culture | Cells grown in a flat layer | Simple, reproducible, and accessible | Weak tissue architecture and mechanical context |
| Organoid | Self-organizing 3D cell structure reproducing selected organ features | Developmental organization and multiple cell types | Variable shape, incomplete maturation, and limited vasculature |
| Engineered tissue | Cells combined with a designed scaffold and controlled forces | Geometry and mechanics can be specified | Manufacturing complexity and material-cell interactions |
| Organ-on-chip | Cells arranged in a microfluidic device with flow and interfaces | Precise control and real-time measurement | Represents only selected functions, not a complete organ |
Why three dimensions matter
Cells sense neighboring cells, matrix composition, geometry, and stiffness. These inputs influence gene expression and function. A heart cell on rigid plastic behaves differently from one in a soft, aligned, beating tissue.
Three-dimensional growth can reproduce gradients of oxygen, nutrients, waste, and signaling. It also creates a transport problem: without vessels, diffusion nourishes only a limited distance, so the centre of a large construct can become oxygen-starved or die.
The vascularization challenge
Real tissues contain branching blood vessels down to capillaries only a few micrometres wide. A transplantable construct needs rapid connection to the recipient's circulation or preformed vessels capable of perfusion. Otherwise, thick tissue cannot receive enough oxygen.
Researchers use endothelial cells, porous scaffolds, sacrificial printed channels, growth factors, and perfusion bioreactors. Creating channels is easier than building a stable vascular network that regulates flow, avoids clots, and integrates with living blood vessels.
Maturation is different from cell identity
A cell can carry the correct markers while remaining developmentally immature. Stem-cell-derived heart muscle often resembles fetal rather than adult muscle in metabolism, size, force, and electrical behavior. Liver, kidney, nerve, and other tissues face similar gaps.
Longer culture, mechanical loading, electrical stimulation, hormones, co-culture, and physiological nutrients can improve maturation. No single marker proves that the entire construct performs like adult tissue.
How scientists verify a tissue model
- Cell identity: single-cell sequencing, proteins, and lineage markers
- Architecture: microscopy, spatial mapping, and extracellular-matrix organization
- Function: contraction, secretion, filtration, conduction, metabolism, or barrier behavior
- Mechanics: stiffness, strength, fatigue, and response to flow or pressure
- Stability: performance over time, batch consistency, and absence of unwanted growth
- Biological relevance: response to disease mutations, drugs, injury, or known physiological stimuli
What laboratory tissues are useful for now
They can reveal developmental mechanisms, reproduce aspects of genetic and acquired disease, compare patient-specific responses, screen drugs, and reduce some animal experiments. They are particularly valuable when conventional cell layers lack the relevant architecture or when animal biology differs from humans.
They do not automatically replace animal studies or clinical trials. A model may reproduce one pathway well while missing immunity, circulation, hormones, organ interactions, dose distribution, or whole-body toxicity.
A heart-valve example
Researchers reported a three-dimensional human heart-valve tissue model derived from pluripotent stem cells. The model could help study valve development, rheumatic disease, and drug responses where animal models are limited. Read Scientists Grow 3D Human Heart-Valve Tissue, but It Is Not an Implant Yet.
A valve model is not yet a replacement valve. An implant must open and close billions of times, withstand changing blood pressure, avoid clotting and harmful immune reactions, grow or remodel appropriately where intended, be sterilizable, and meet reproducible manufacturing and regulatory standards.
What makes transplantation harder?
| Requirement | Why it is hard |
|---|---|
| Purity and safety | Residual pluripotent cells can form unwanted tissue or tumors. |
| Immune compatibility | Patient-specific cells take time; donor cells may be rejected. |
| Vessels and nerves | Thick or functional tissues need perfusion and often neural integration. |
| Mechanical durability | Implants face years of load, motion, and fatigue. |
| Manufacturing consistency | Every batch must meet defined identity, potency, sterility, and stability limits. |
| Integration | The construct must connect anatomically and functionally without dangerous rhythms, leaks, or scarring. |
The mental model
Growing tissue is closer to guiding development than assembling a device. Researchers provide cells with a timed environment, let biological self-organization do part of the work, and engineer the geometry and forces biology cannot supply alone. The nearer the goal moves from a disease model toward an implant, the more demanding the requirements become.
First appeared in
Scientists Grow 3D Human Heart-Valve Tissue, but It Is Not an Implant Yet